Related Experiment Video
Updated: Aug 1, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Hypertension in Patients Treated With In-Center Maintenance Hemodialysis: Current Evidence and Future Opportunities:
Insights
Hypertension affects over 80% of patients on maintenance hemodialysis, a key factor in their high cardiovascular mortality. This review covers defining, diagnosing, and treating this condition in hemodialysis patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Hypertension Research
Background:
- Over 500,000 individuals in the US undergo maintenance hemodialysis for kidney failure.
- Cardiovascular disease causes approximately 50% of deaths in this patient population.
- Hypertension is prevalent in >80% of hemodialysis patients and is a modifiable cardiovascular risk factor.
Purpose of the Study:
- To review current evidence on hypertension in patients undergoing maintenance hemodialysis.
- To discuss the definition, diagnosis, and treatment of hypertension in this specific population.
- To identify areas for future research, including optimal blood pressure targets and therapeutic strategies.
Main Methods:
- Literature review of existing scientific evidence.
- Analysis of multifactorial pathophysiology of hypertension in hemodialysis.
- Synthesis of current guidelines and research findings.
Main Results:
- Hypertension pathophysiology in hemodialysis patients is complex and distinct.
- Contributing factors include volume overload, arterial stiffness, sympathetic and renin-angiotensin-aldosterone system activity, endothelial dysfunction, and erythropoietin-stimulating agent use.
- Evidence on optimal management strategies requires further investigation.
Conclusions:
- Hypertension is a critical issue in maintenance hemodialysis patients, significantly contributing to cardiovascular mortality.
- Understanding the unique pathophysiology is essential for effective management.
- Further research is needed to establish evidence-based blood pressure targets and treatment protocols.
Abstract:
Nearly 500 000 individuals are treated with maintenance hemodialysis for kidney failure in the United States, and roughly half will die of cardiovascular causes. Hypertension, an important and modifiable risk factor for cardiovascular disease, is observed in >80% of patients treated with maintenance hemodialysis. The pathophysiology of hypertension in patients treated with maintenance hemodialysis is multifactorial and differs from that seen in other patient populations. Factors that contribute to hypertension in patients treated with hemodialysis include volume overload, arterial stiffness, enhanced activity of the sympathetic nervous and renin-angiotensin-aldosterone systems, endothelial dysfunction, and use of erythropoietin-stimulating agents. This scientific statement reviews the current evidence on defining, diagnosing, and treating hypertension in patients treated with maintenance hemodialysis and highlights opportunities for future investigation, including studies on blood pressure targets and treatment strategies.
More Related Videos
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hemodialysis I: Introduction

